Evidence map›Paper›PMID 38513161›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Cancer Treatment Disparities in People With HIV in the United States, 2001-2019.

Jennifer K McGee-Avila, Gita Suneja, Eric A Engels, Anne F Rositch, Marie-Josephe Horner, Qianlai Luo, Meredith S Shiels, Jessica Y Islam

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Viral oncogenesis in cancer: from mechanisms to therapeutics.Signal transduction and targeted therapy · 2025
    Review
  16. Article
  17. Article
  18. [How I treat lymphomas associated with HIV infection].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025
    Article
  19. Article
  20. Prostate cancer in people with HIV.Current opinion in infectious diseases · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jennifer K McGee-AvilaInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD.ORCID 0000-0002-0425-015X
Gita SunejaDepartment of Radiation Oncology, University of Utah, School of Medicine, Salt Lake City, UH.ORCID 0000-0002-5933-211X
Eric A EngelsInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD.ORCID 0000-0003-0203-6958
Anne F RositchDeparment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.ORCID 0000-0002-0403-8482
Marie-Josephe HornerTrans-Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.ORCID 0000-0003-0651-5788
Qianlai LuoInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD.ORCID 0000-0001-9390-9448
Meredith S ShielsInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD.ORCID 0000-0001-8390-6091
Jessica Y IslamCancer Epidemiology Program, Center for Immunization and Infection in Cancer, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.ORCID 0000-0002-3690-3848
National Cancer Institute · USJohns Hopkins University · USMoffitt Cancer Center · USUniversity of Utah · US

Funding

GEORGIA COMPREHENSIVE CANCER CONTROL PROGRAMU58DP003875 · DP · GEORGIA DIVISION OF PUBLIC HEALTH · PI O'CONNOR, JEAN CATHERINE · 2012 to 2014
$15.9M
NEW JERSEY CANCER PREVENTION & CONTROL PROGRAMU58DP003931 · DP · NEW JERSEY STATE DEPT/HEALTH/SENIOR SRVS · PI RODRIQUEZ, GLORIA · 2012 to 2014
$11.9M
National HIV Surveillance SystemU62PS004001 · PS · NEW JERSEY STATE DEPT/HEALTH/SENIOR SRVS · PI BOLDEN, BARBARA JEAN · 2013 to 2016
$8.9M
HIV/AIDS SURVEILLANCEU62PS001005 · PS · CONNECTICUT STATE DEPT OF PUBLIC HEALTH · PI ROOME, AARON · 2008 to 2012
$4.7M
Core and Incidence Surveillance for HIV in MichiganU62PS004011 · PS · MICHIGAN STATE DEPARTMENT OF HEALTH AND HUMAN SERVICES · PI MACOMBER, KATHRYN EMERY · 2013 to 2016
$3.7M
Prioritizing county-level social determinants that contribute to the greater burden of diabetes and hypertension in the USU01DP006302 · DP · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CARSON, APRIL P · 2017 to 2021
$3.6M
NATIONAL HIV SURVEILLANCE SYSTEM (NHSS)U62PS003960 · PS · COLORADO STATE DEPT/PUB HLTH & ENVIRONMT · PI MATTSON, MELANIE · 2013 to 2016
$2.9M
ACL HHS U01DP006302NCCDPHP CDC HHS U01 DP006302NCCDPHP CDC HHS U58 DP003875NCCDPHP CDC HHS U58 DP003931NCHHSTP CDC HHS U62 PS001005NCHHSTP CDC HHS U62 PS003960NCHHSTP CDC HHS U62 PS004001NCHHSTP CDC HHS U62 PS004011NCI NIH HHS HHSN261201300019CNCI NIH HHS HHSN261201300019INCI NIH HHS HHSN261201300021CNCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009I
6 · The paper itself

Abstract

purposePeople with HIV (PWH) have worse cancer outcomes, partially because of inequities in cancer treatment. We evaluated cancer treatment disparities among PWH, including an assessment of changes in disparities over time.

methodsWe used data from the HIV/AIDS Cancer Match Study, a population-based HIV and cancer registry linkage to examine diffuse large B-cell lymphoma (DLBCL), Hodgkin lymphoma (HL), and cancers of the cervix, lung, anus, prostate, colon, and female breast. Outcomes included receipt of (1) any cancer treatment and (2) standard therapy among patients with local-stage cancer. We assessed associations between HIV and each outcome by estimating adjusted prevalence odds ratios (aORs) with 95% CI and trends over time. We identified predictors of nonreceipt of cancer treatment in PWH.

resultsFrom 2001 to 2019, compared with people with cancer without HIV (n = 2,880,955), PWH (n = 16,334) were more likely to not receive cancer treatment for cervical cancer (aOR, 2.03 [95% CI, 1.52 to 2.70]), DLBCL (aOR, 1.53 [95% CI, 1.38 to 1.70]), HL (aOR, 1.39 [95% CI, 1.19 to 1.63]), lung cancer (aOR, 1.79 [95% CI, 1.65 to 1.93]), prostate cancer (aOR, 1.32 [95% CI, 1.21 to 1.44]), colon cancer (aOR, 1.73 [95% CI, 1.43 to 2.08]), and breast cancer (aOR, 1.38 [95% CI, 1.07 to 1.77]). Similar associations were observed in PWH with local-stage cancers although no difference was observed for anal cancers. The association between HIV and nonreceipt of cancer treatment significantly decreased over time for breast, colon, and prostate cancers (all

conclusionDisparities in receipt of cancer treatment persist for PWH in the United States in contemporary time periods. Solutions to address inequitable receipt of cancer treatment among PWH are urgently needed.

Indexed as

Healthcare DisparitiesHIV InfectionsNeoplasmsAdultAgedFemaleHumansMaleMiddle AgedRegistriesUnited StatesYoung Adult

Identifiers

PMID38513161
PMCPMC11095899
OpenAlexW4393031625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.